If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEngage Xr Regulatory News (EXR)

Share Price Information for Engage Xr (EXR)

Share Price is delayed by 15 minutes
Get Live Data
0.25    0.025 (11.11%)
Bid:
0.20
Ask:
0.30
Spread: 0.10 (50.00%)
Market Cap: £1.31m
EXR Live PriceLast checked at - London Stock Exchange

Intraday Engage Xr Share Chart

EPT Disclosure

2 Jun 2008 11:31

RNS Number : 7364V
UBS AG (EPT)
02 June 2008
Β 

ο»Ώ

FORM 38.5(b)

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERSΒ 

WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS

BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(b) of the Takeover Code)

Β 

Β 

1. KEY INFORMATION

Β 

Name of exempt principal trader

UBS AGΒ LondonΒ Branch

Company dealt in

Expro International Group Plc

Class of relevant security to which the dealings being disclosed relateΒ (Note 1)

10p Ordinary

Date of dealing

30Β MAY 2008

Β 

Β 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

Β 

(a) Interests and short positions (following dealing) in the class ofΒ 

relevant security dealt inΒ (Note 2)

Β 

Β 

Long

Β 

Short

Β 

Β 

Number

(%)

NumberΒ 

(%)

(1) Relevant securitiesΒ 

469,077

0.42%

0

0.00%

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

469,077

0.42%

0

0.00%

(b) Interests and short positions in relevant securities of

the company, other than the class dealt in (NoteΒ 2)

Β 

Class of relevant security:

Long

Β 

Short

Β 

Β 

NumberΒ 

(%)

Number

(%)

(1) Relevant securitiesΒ 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

Β 

Rights to subscribeΒ (Note 2)

Class of relevant security:

Details

3. DEALINGSΒ (Note 3)

Β (a) Purchases and sales

Purchase/sale

Number of securities

Price per unit (Note 4)

SALE

50000

1608.5835Β pence

PURCHASE

602

1609

SALE

3533

1610

SALE

3000

1610

SALE

638

1610

SALE

487

1610

PURCHASE

471

1610

PURCHASE

625

1610

PURCHASE

842

1610

PURCHASE

1420

1610

PURCHASE

1666

1610

PURCHASE

3533

1610

SALE

1116

1611

SALE

546

1611

SALE

375

1611

SALE

354

1611

SALE

35

1611

PURCHASE

115

1611

PURCHASE

115

1611

PURCHASE

157

1611

PURCHASE

200

1611

PURCHASE

262

1611

PURCHASE

422

1611

PURCHASE

500

1611

PURCHASE

518

1611

PURCHASE

789

1611

PURCHASE

876

1611

PURCHASE

1006

1611

PURCHASE

4393

1611

SALE

774

1612

SALE

546

1612

SALE

375

1612

SALE

355

1612

SALE

293

1612

SALE

258

1612

SALE

200

1612

SALE

100

1612

SALE

53

1612

SALE

26

1612

PURCHASE

30

1612

PURCHASE

103

1612

PURCHASE

111

1612

PURCHASE

127

1612

PURCHASE

130

1612

PURCHASE

306

1612

PURCHASE

751

1612

PURCHASE

1067

1612

PURCHASE

1380

1612

SALE

234

1613

SALE

200

1613

PURCHASE

200

1613

PURCHASE

200

1613

PURCHASE

1082

1613

SALE

510

1614

SALE

359

1614

SALE

344

1614

SALE

200

1614

PURCHASE

246

1614

PURCHASE

246

1614

PURCHASE

415

1614

PURCHASE

641

1614

SALE

1891

1615

SALE

661

1615

SALE

415

1615

PURCHASE

115

1615

PURCHASE

675

1615

PURCHASE

2

1616

PURCHASE

310

1616

PURCHASE

374

1616

PURCHASE

402

1616

PURCHASE

500

1616

PURCHASE

500

1616

PURCHASE

641

1616

PURCHASE

731

1616

PURCHASE

1000

1616

PURCHASE

1000

1616

TOTAL PURCHASES

31,797

TOTAL SALES

67,878

(b) Derivatives transactions (other than options)

Product name, e.g CFD

Long/shortΒ (Note 5)

Number of securitiesΒ (Note 6)

Price per unitΒ (Note 4)

Β 

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Β 

Product name,e.g. call option

Writing, selling, purchasing, varying etc

Number of securities to which the option relatesΒ (Note 6)

Exercise priceΒ 

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unitΒ (Note 4)

Β 

(ii) Exercising

Β 

Product name, e.g. call option

Number of securitiesΒ 

Exercise price per unit (Note 4)

Β 

(d) Other dealings (including new securities)Β (Note 3)

Β 

Nature of transaction(Note 7)

Details

Price per unit (if applicable)

Β 

4. OTHER INFORMATION

Β 

Agreements, arrangements or understandings relating to options or derivatives

Β 

Β 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Β 

……………………………………………………………………

Β 

……………………………………………………………………

Β 

Is a Supplemental Form 38.5(b) attached?Β (Note 8) NO

Β 

Date of disclosure

2 JUNEΒ 2008

Contact name

LOUISE ROBINSON

Telephone number

020 7567 8762

Name of offeree/offeror with which connected

Halliburton Company

Nature of connection (Note 9)

CONNECTED ADVISER

Notes

The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
EMMBGGDLBXGGGID
Date   Source Headline
26th Apr 20067:02 amRNSDirectorate Change
28th Mar 20067:00 amRNSTrading Statement
13th Feb 20064:32 pmRNSDirector/PDMR Shareholding
13th Feb 20064:31 pmRNSDirector/PDMR Shareholding
13th Feb 20063:09 pmRNSAdditional Listing
13th Feb 20062:42 pmRNSBlocklisting Interim Review
12th Jan 20064:00 pmRNSInvestor Presentation
11th Jan 20068:08 amRNSPositive Forecast Update
13th Dec 20057:01 amRNSRe Contract
24th Nov 200512:06 pmRNSDividend Amendment
24th Nov 20057:02 amRNSInterim Results
15th Nov 20053:35 pmRNSSale of QuantX
15th Nov 20057:01 amRNSIFRS Restatements
7th Nov 200511:49 amRNSAdditional Listing
3rd Nov 20054:35 pmRNSHolding(s) in Company
2nd Nov 200511:00 amRNSNotice of Results
28th Sep 20057:01 amRNSTrading Statement
15th Sep 200510:28 amRNSBlocklisting Interim Review
19th Jul 20057:00 amRNSInvestor Visits
8th Jul 200511:25 amRNSInvestor Visit
6th Jul 20053:27 pmRNSAGM Statement
27th Jun 20052:24 pmRNSAnnual Report and Accounts
10th Jun 20058:51 amRNSDirector Shareholding
8th Jun 20059:43 amRNSDirector Shareholding
8th Jun 20059:42 amRNSDirector Shareholding
8th Jun 20059:35 amRNSDirector Shareholding
2nd Jun 200510:01 amRNSResult of Placing
2nd Jun 20057:02 amRNSCash Placing
2nd Jun 20057:02 amRNSFinal Results
23rd May 20059:07 amRNSNotice of Results
13th Apr 20057:00 amRNSAcquisition
24th Mar 20051:30 pmRNSCapital Reorganisation
22nd Mar 20057:01 amRNSTrading Statement
24th Feb 20053:34 pmRNSBlocklisting Interim Review
24th Feb 20051:09 pmRNSDirector Shareholding
23rd Feb 200511:35 amRNSEGM - Capital Reorganisation
18th Feb 20057:02 amRNSRe Contract
9th Feb 20052:00 pmRNSRe Contract
2nd Feb 20057:00 amRNSAcquisition
1st Feb 20055:56 pmRNSDirector Shareholding
28th Jan 20057:00 amRNSCapital Reorganisation
10th Jan 20055:05 pmRNSDirector Shareholding
10th Jan 20055:03 pmRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.